# Question 26

**Type:** Gene Panels

**Question:** What percentage of genomic events in the MSK-CHORD Study occur in genes that are off-panel (not covered by the sequencing panel used)?

**Answer:**

I'll help you find the percentage of genomic events that occur in off-panel genes in the MSK-CHORD study. Let me start by exploring the available data structure.



Calling `get_study_guide` with args:
```json
{
  "study_id": "msk_chord_2024"
}
```



Result from `get_study_guide`:
```json
# MSK-CHORD (MSK, Nature 2024)

**Study ID:** `msk_chord_2024`

## Overview
Targeted sequencing via MSK-IMPACT panels. Clinical annotations include some derived from natural language processing (denoted NLP).

## Gene Panels
This study uses multiple MSK-IMPACT panel versions:
- **IMPACT341**: Earlier version, 341 genes
- **IMPACT410**: 410 genes
- **IMPACT468**: 468 genes  
- **IMPACT505**: Latest version, 505 genes

**Important:** Different samples may have different gene coverage. Always use gene-specific denominators when calculating mutation frequencies.

## Clinical Attributes - Semantic Guide

### Cancer Classification
| Attribute | Description | Values |
|-----------|-------------|--------|
| `CANCER_TYPE` | Broad cancer category | e.g., "Non-Small Cell Lung Cancer", "Breast Cancer" |
| `CANCER_TYPE_DETAILED` | Specific subtype | e.g., "Lung Adenocarcinoma", "Invasive Ductal Carcinoma" |
| `ONCOTREE_CODE` | OncoTree classification code | Standardized cancer type codes |

### Sample Information
| Attribute | Description | Values |
|-----------|-------------|--------|
| `SAMPLE_TYPE` | Sample origin | Primary, Metastasis, Local Recurrence, Unknown |
| `SAMPLE_CLASS` | Sample classification | Tumor, Normal |
| `PRIMARY_SITE` | Anatomical primary site | e.g., Lung, Breast, Colon |
| `METASTATIC_SITE` | Site of metastasis (if applicable) | e.g., Liver, Bone, Brain |

#### Sample Type Distribution (as of 2024)
| Sample Type | Count | Notes |
|-------------|-------|-------|
| **Primary** | 15,928 | Primary tumor samples |
| **Metastasis** | 8,878 | Metastatic tumor samples |
| **Unknown** | 136 | Sample type not specified |
| **Local Recurrence** | 98 | Locally recurrent tumors |
| **Total** | **25,040** | All samples in study |

**ðŸš¨ CRITICAL:** To query primary/metastatic samples, use `clinical_data_derived` with `attribute_name = 'SAMPLE_TYPE'`:
```sql
-- CORRECT way to count primary samples
SELECT COUNT(DISTINCT sample_unique_id) as primary_samples
FROM clinical_data_derived
WHERE cancer_study_identifier = 'msk_chord_2024'
  AND attribute_name = 'SAMPLE_TYPE'
  AND attribute_value = 'Primary';
-- Returns: 15,928

-- DO NOT use sample.sample_type column - it contains "Primary Solid Tumor" for ALL samples!
```

### Genomic Features
| Attribute | Description | Notes |
|-----------|-------------|-------|
| `TMB_NONSYNONYMOUS` | Tumor mutational burden | Nonsynonymous mutations per Mb |
| `MUTATION_COUNT` | Total mutation count | Raw count of mutations in sample |
| `MSI_SCORE` | Microsatellite instability score | Numeric score |
| `MSI_TYPE` | MSI classification | Stable, Instable, Indeterminate |

### Clinical Groupings
| Attribute | Description | Notes |
|-----------|-------------|-------|
| `CLINICAL_GROUP` | Clinical grouping | Study-specific grouping |
| `PATHOLOGICAL_GROUP` | Pathological grouping | Study-specific grouping |
| `CLINICAL_SUMMARY` | NLP-derived clinical summary | May contain extracted clinical info |

### Prostate-Specific
| Attribute | Description |
|-----------|-------------|
| `GLEASON_SAMPLE_LEVEL` | Gleason score at sample level |
| `GLEASON_FIRST_REPORTED` | First reported Gleason score |
| `GLEASON_HIGHEST_REPORTED` | Highest reported Gleason score |

### Biomarkers
| Attribute | Description |
|-----------|-------------|
| `PDL1_POSITIVE` | PD-L1 expression status |
| `HISTORY_OF_PDL1` | History of PD-L1 testing |
| `HER2` | HER2 status (breast cancer) |
| `HR` | Hormone receptor status |

## Treatment Data

MSK-CHORD has **detailed treatment data** stored in clinical_event tables. This is one of the most comprehensive treatment datasets in cBioPortal.

### Treatment Event Keys

| Key | Description | Example Values |
|-----|-------------|----------------|
| `AGENT` | Drug/treatment name | FLUOROURACIL, PEMBROLIZUMAB, OXALIPLATIN |
| `SUBTYPE` | Treatment category | Chemo, Immuno, Targeted, Hormone, Radiation Therapy |
| `RX_INVESTIGATIVE` | Investigational drug flag | Y, N |
| `FLAG_OROTOPICAL` | Oral/topical administration | 0, 1 |
| `TREATMENT_TYPE` | Broad treatment type | Medical Therapy |
| `PRIOR_MED_TO_MSK` | Prior medications flag | Indicates meds before MSK care |
| `INFERRED_TX_PROB` | NLP inference probability | Confidence score for NLP-extracted data |

### Treatment Subtypes

| Subtype | Description |
|---------|-------------|
| `Chemo` | Cytotoxic chemotherapy |
| `Targeted` | Molecularly targeted agents (TKIs, etc.) |
| `Immuno` | Immunotherapy (checkpoint inhibitors, etc.) |
| `Hormone` | Hormonal therapy |
| `Radiation Therapy` | Radiation treatment |
| `Biologic` | Biologic agents |
| `Investigational` | Investigational/trial drugs |
| `Bone Treatment` | Bone-targeted agents (bisphosphonates, etc.) |
| `Prior Medications to MSK` | Medications before MSK treatment |

### Query Examples

```sql
-- Get treatments by subtype
SELECT 
    subtype.value as treatment_type,
    agent.value as agent,
    COUNT(DISTINCT ce.patient_id) as patients
FROM clinical_event ce
JOIN clinical_event_data agent ON ce.clinical_event_id = agent.clinical_event_id AND agent.key = 'AGENT'
JOIN clinical_event_data subtype ON ce.clinical_event_id = subtype.clinical_event_id AND subtype.key = 'SUBTYPE'
JOIN patient p ON ce.patient_id = p.internal_id
JOIN cancer_study cs ON p.cancer_study_id = cs.cancer_study_id
WHERE cs.cancer_study_identifier = 'msk_chord_2024'
  AND ce.event_type IN ('Treatment', 'TREATMENT')
GROUP BY subtype.value, agent.value
ORDER BY treatment_type, patients DESC;
```

### Treatment Data Caveats
- Some treatment data is NLP-extracted (`INFERRED_TX_PROB` indicates confidence)
- `PRIOR_MED_TO_MSK` captures pre-MSK treatments separately
- Treatment timing (start_date, stop_date) is in days from diagnosis
- **Cannot calculate percentages**: We can't distinguish "not collected" from "not received"

### Treatment Query Patterns for MSK-CHORD

**For broad questions** ("What treatments did patients receive?"):
1. First summarize by SUBTYPE (Chemo, Immuno, Targeted, etc.)
2. Then list top agents within each category

**For specific questions** ("Most common treatment?"):
- Query by AGENT key
- Report patient count, NOT percentage
- Expected answer: Fluorouracil (~6,319 patients)

**For treatment type questions** ("Most common chemotherapy?"):
- Filter by `SUBTYPE = 'Chemo'` and report by AGENT

## Notes & Caveats
- Some clinical annotations are NLP-derived and may have extraction errors
- Multiple IMPACT panel versions mean gene coverage varies by sample
- Data is under CC BY-NC-ND 4.0 license; contact datarequests@mskcc.org for commercial use

```




Calling `clickhouse_list_tables` with args:
```json
{}
```



Result from `clickhouse_list_tables`:
```json
{"tables":[{"name":"allele_specific_copy_number","total_rows":0,"comment":"Allele-specific CNA data for mutations. References mutation_event, genetic_profile, and sample."},{"name":"alteration_driver_annotation","total_rows":37356,"comment":"Annotations for genetic alterations classified as potential drivers. References genetic_profile and sample."},{"name":"cancer_study","total_rows":511,"comment":"Contains metadata for each cancer study in the portal. References type_of_cancer and reference_genome."},{"name":"cancer_study_tags","total_rows":0,"comment":"Tags associated with a cancer study. References cancer_study."},{"name":"clinical_attribute_meta","total_rows":18230,"comment":"Metadata describing clinical attributes. References cancer_study."},{"name":"clinical_data_derived","primary_key":"cancer_study_identifier, type, attribute_name, sample_unique_id","total_rows":11763690,"comment":"Unified clinical data table combining both patient-level and sample-level clinical attributes in a normalized key-value format. Uses FULL OUTER JOIN to ensure all defined clinical attributes appear for each patient/sample, even when no value is recorded (populated with empty string). Enables efficient querying of clinical data across different attribute types and levels."},{"name":"clinical_event","total_rows":2643379,"comment":"Time-bound clinical events for patients. References patient."},{"name":"clinical_event_data","total_rows":14395558,"comment":"Key-value attributes for clinical events. References clinical_event."},{"name":"clinical_event_derived","primary_key":"cancer_study_identifier, event_type, patient_unique_id","total_rows":14422476,"comment":"Denormalized clinical timeline events table combining temporal clinical events with their associated key-value attributes. Each row represents a specific attribute of a clinical event (e.g., treatment, surgery, specimen collection) with start/stop dates. Flattens the normalized clinical_event and clinical_event_data relationship into a queryable format for timeline analysis."},{"name":"clinical_patient","total_rows":4157292,"comment":"Patient-level clinical attribute values. References patient."},{"name":"clinical_sample","total_rows":5323875,"comment":"Sample-level clinical attribute values. References sample."},{"name":"cna_event","total_rows":77018,"comment":"Copy number alteration event definition. References gene."},{"name":"copy_number_seg","total_rows":28149618,"comment":"Raw segmented copy number data. References cancer_study and sample."},{"name":"copy_number_seg_file","total_rows":292,"comment":"File metadata for segmented copy number input. References cancer_study."},{"name":"gene","total_rows":46303,"comment":"Gene metadata (Entrez ID, HUGO symbol). References genetic_entity."},{"name":"gene_alias","total_rows":75207,"comment":"Alternative symbols/aliases for genes. References gene."},{"name":"gene_panel","total_rows":58,"comment":"Defines a targeted gene panel used in sequencing."},{"name":"gene_panel_list","total_rows":21477,"comment":"Join table linking gene panels to genes. References gene_panel and gene."},{"name":"generic_assay_data_derived","primary_key":"profile_type, entity_stable_id, patient_unique_id, sample_unique_id","total_rows":394482832,"comment":"Denormalized generic assay data table that unpivots wide-format genetic_alteration values for generic assay profiles into a long-format structure. Handles diverse assay types like treatment response, phosphosite quantification, and other non-genomic measurements. Each row represents one entity-sample combination with its measured value. Supports both sample-level and patient-level data based on profile configuration."},{"name":"generic_entity_properties","total_rows":2490012,"comment":"Properties for generic entities. References genetic_entity."},{"name":"geneset","total_rows":34837,"comment":"Collection of genes grouped into functional sets. References genetic_entity."},{"name":"geneset_gene","total_rows":8050756,"comment":"Join table linking genesets to genes. References geneset and gene."},{"name":"geneset_hierarchy_leaf","total_rows":0,"comment":"Mapping of hierarchy nodes to specific gene sets. References geneset_hierarchy_node and geneset."},{"name":"geneset_hierarchy_node","total_rows":0,"comment":"Hierarchy node for organizing gene sets. May reference parent node within same table."},{"name":"genetic_alteration","primary_key":"genetic_profile_id, genetic_entity_id","total_rows":33488996,"comment":"Stores genetic alteration values (for many genetic alteration types. e.g. MRNA_EXPRESSION, PROTEIN_LEVEL, GENERIC_ASSAY,...). References genetic_profile and genetic_entity."},{"name":"genetic_alteration_derived","primary_key":"cancer_study_identifier, hugo_gene_symbol, profile_type, sample_unique_id","total_rows":10133300301,"comment":"Denormalized genetic alteration data table that unpivots the wide-format genetic_alteration values into a long-format structure. Each row represents one gene-sample-profile combination with its alteration value. Excludes mutation data (handled separately) and generic assays, focusing on continuous/discrete data like expression, methylation, and copy number. Filters out \"NA\" values to reduce storage and improve query performance."},{"name":"genetic_entity","total_rows":2508068,"comment":"Abstract entity representing a gene, gene set, or other genomic element."},{"name":"genetic_profile","total_rows":2405,"comment":"Defines a molecular profile (e.g. mutations, CNA, mRNA expression). References cancer_study."},{"name":"genetic_profile_link","total_rows":2,"comment":"Links between genetic profiles. References genetic_profile (source and target)."},{"name":"genetic_profile_samples","total_rows":1896,"comment":"Stores ordered sample lists for a genetic profile (for many genetic alteration types. e.g. MRNA_EXPRESSION, PROTEIN_LEVEL, GENERIC_ASSAY,...). References genetic_profile."},{"name":"genomic_event_derived","primary_key":"genetic_profile_stable_id, cancer_study_identifier, variant_type, entrez_gene_id, hugo_gene_symbol, sample_unique_id","total_rows":48903328,"comment":"Unified genomic events table combining mutations, copy number alterations (CNA), and structural variants into a single denormalized view. Each row represents a gene-level genomic event observed in a sample. Structural variants are split into separate rows for site1 and site2 genes (excluding duplicates). Includes off-panel detection to identify events in genes not covered by the associated gene panel."},{"name":"gistic","total_rows":3547,"comment":"GISTIC-identified copy number alteration regions. References cancer_study."},{"name":"gistic_to_gene","total_rows":204806,"comment":"Mapping of GISTIC regions to genes. References gistic and gene."},{"name":"info","total_rows":1},{"name":"mut_sig","total_rows":2850,"comment":"MutSig significance analysis results. References cancer_study and gene."},{"name":"mutation","primary_key":"genetic_profile_id, entrez_gene_id","total_rows":17774534,"comment":"Mutation observations in specific samples and profiles. References mutation_event, gene, genetic_profile, and sample."},{"name":"mutation_count_by_keyword","total_rows":12451447,"comment":"Stores keyword-based aggregated mutation counts. References genetic_profile and gene."},{"name":"mutation_event","total_rows":8850403,"comment":"Defines unique mutation events (by position, gene, allele change). References gene."},{"name":"patient","total_rows":320721,"comment":"Stores patient-level identifiers of patients enrolled in a cancer study. References cancer_study."},{"name":"reference_genome","total_rows":3,"comment":"Reference genome definitions (e.g. hg19, GRCh38)."},{"name":"reference_genome_gene","total_rows":84612,"comment":"Mapping of reference genome builds to genes. References reference_genome and gene."},{"name":"resource_definition","total_rows":43,"comment":"Definitions of external resources (study, patient, sample level). References cancer_study."},{"name":"resource_patient","total_rows":10471,"comment":"Links external resources to patients. References patient."},{"name":"resource_sample","total_rows":3711,"comment":"Links external resources to samples. References sample."},{"name":"resource_study","total_rows":0,"comment":"Links external resources to cancer studies. References cancer_study."},{"name":"sample","total_rows":336873,"comment":"Biological samples collected from patients. References patient."},{"name":"sample_cna_event","primary_key":"genetic_profile_id, cna_event_id, sample_id","total_rows":30879655,"comment":"Observed CNA events per sample and profile. References cna_event, sample, and genetic_profile."},{"name":"sample_derived","primary_key":"cancer_study_identifier, sample_unique_id","total_rows":336873,"comment":"Denormalized sample table with globally unique identifiers and enriched metadata. Combines sample, patient, and cancer_study data with computed flags for sequencing status and copy number segment availability. Optimized for summary and detailed projections with base64-encoded identifiers for URL-safe usage."},{"name":"sample_list","total_rows":2727,"comment":"Named collections of samples within a study. References cancer_study."},{"name":"sample_list_list","total_rows":1452133,"comment":"Join table linking sample lists to samples. References sample and sample_list."},{"name":"sample_profile","total_rows":1090903,"comment":"Links samples to genetic profiles, optionally via a gene panel. References sample, genetic_profile, and gene_panel."},{"name":"sample_to_gene_panel_derived","primary_key":"gene_panel_id, alteration_type, genetic_profile_id, sample_unique_id","total_rows":1090903,"comment":"Denormalized mapping table linking samples to their associated gene panels for each genetic alteration type. Derived from sample_profile, genetic_profile, gene_panel, sample, and cancer_study tables. Defaults to WES (Whole Exome Sequencing) when no specific gene panel is assigned."},{"name":"structural_variant","total_rows":148760,"comment":"Structural variant data (fusions, translocations). References genetic_profile, sample, and gene (site1/site2)."},{"name":"type_of_cancer","total_rows":898,"comment":"Lookup table for cancer types."}]}
```


Great! I can see there's a `genomic_event_derived` table that includes "off-panel detection to identify events in genes not covered by the associated gene panel." Let me examine this table more closely.



Calling `clickhouse_list_table_columns` with args:
```json
{
  "table": "genomic_event_derived"
}
```



Result from `clickhouse_list_table_columns`:
```json
{"columns":[{"name":"sample_unique_id","type":"String","comment":"Globally unique sample identifier constructed as cancer_study_identifier + \"_\" + sample.stable_id to ensure uniqueness across all studies."},{"name":"hugo_gene_symbol","type":"String","comment":"Official HUGO gene symbol for the affected gene. References gene.hugo_gene_symbol."},{"name":"entrez_gene_id","type":"Int32","comment":"Entrez Gene ID for the affected gene. References gene.entrez_gene_id."},{"name":"gene_panel_stable_id","type":"LowCardinality(String)","comment":"Identifier of the gene panel used for this sample. Defaults to \"WES\" (Whole Exome Sequencing) when no specific panel is assigned."},{"name":"cancer_study_identifier","type":"LowCardinality(String)","comment":"Stable string identifier for the cancer study. References cancer_study.cancer_study_identifier."},{"name":"genetic_profile_stable_id","type":"LowCardinality(String)","comment":"Stable identifier of the genetic profile containing this event. References genetic_profile.stable_id."},{"name":"variant_type","type":"LowCardinality(String)","comment":"Type of genomic variant: \"mutation\" for point mutations/indels, \"cna\" for copy number alterations, \"structural_variant\" for structural rearrangements."},{"name":"mutation_variant","type":"String","comment":"Protein-level change for mutations (e.g., p.V600E). Set to \"NA\" for non-mutation events. References mutation_event.protein_change."},{"name":"mutation_type","type":"LowCardinality(String)","comment":"Classification of mutation type (e.g., Missense, Nonsense, Frame_Shift). Set to \"NA\" for non-mutation events. References mutation_event.mutation_type."},{"name":"mutation_status","type":"LowCardinality(String)","comment":"Mutation status: Germline, Somatic, or LOH. Set to \"NA\" for non-mutation events. References mutation.mutation_status."},{"name":"driver_filter","type":"LowCardinality(String)","comment":"Driver annotation filter applied to the alteration. Currently set to \"NA\" for all events (driver annotations not yet implemented)."},{"name":"driver_tiers_filter","type":"LowCardinality(String)","comment":"Driver tiers annotation filter. Currently set to \"NA\" for all events (driver annotations not yet implemented)."},{"name":"cna_alteration","type":"Nullable(Int8)","comment":"Copy number alteration value (e.g., -2 for deep deletion, +2 for amplification). NULL for non-CNA events. References cna_event.alteration."},{"name":"cna_cytoband","type":"String","comment":"Cytogenetic band location of the gene for CNA events. Empty string for non-CNA events. References reference_genome_gene.cytoband."},{"name":"sv_event_info","type":"String","comment":"Additional information about structural variant events. Empty string for non-SV events. References structural_variant.event_info."},{"name":"patient_unique_id","type":"String","comment":"Globally unique patient identifier constructed as cancer_study_identifier + \"_\" + patient.stable_id to ensure uniqueness across all studies."},{"name":"off_panel","type":"Bool","comment":"Boolean flag indicating whether this genomic event occurred in a gene not covered by the associated gene panel (TRUE=off-panel, FALSE=on-panel). Determined by checking presence in gene_panel_to_gene_derived table."}]}
```


Perfect! The `genomic_event_derived` table has an `off_panel` column that indicates whether each genomic event occurred in a gene not covered by the sequencing panel. Now let me query the data to calculate the percentage of off-panel events in the MSK-CHORD study.



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT \n    COUNT(*) as total_events,\n    SUM(CASE WHEN off_panel = true THEN 1 ELSE 0 END) as off_panel_events,\n    SUM(CASE WHEN off_panel = false THEN 1 ELSE 0 END) as on_panel_events,\n    ROUND(100.0 * SUM(CASE WHEN off_panel = true THEN 1 ELSE 0 END) / COUNT(*), 2) as off_panel_percentage\nFROM genomic_event_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"total_events":279212,"off_panel_events":2849,"on_panel_events":276363,"off_panel_percentage":1.02}]}
```


Let me also break this down by variant type to provide more detailed insights:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT \n    variant_type,\n    COUNT(*) as total_events,\n    SUM(CASE WHEN off_panel = true THEN 1 ELSE 0 END) as off_panel_events,\n    SUM(CASE WHEN off_panel = false THEN 1 ELSE 0 END) as on_panel_events,\n    ROUND(100.0 * SUM(CASE WHEN off_panel = true THEN 1 ELSE 0 END) / COUNT(*), 2) as off_panel_percentage\nFROM genomic_event_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\nGROUP BY variant_type\nORDER BY total_events DESC\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"variant_type":"mutation","total_events":208214,"off_panel_events":150,"on_panel_events":208064,"off_panel_percentage":0.07},{"variant_type":"cna","total_events":60787,"off_panel_events":0,"on_panel_events":60787,"off_panel_percentage":0.0},{"variant_type":"structural_variant","total_events":10211,"off_panel_events":2699,"on_panel_events":7512,"off_panel_percentage":26.43}]}
```


Excellent! Now let me get some additional context about the most common off-panel genes:



Calling `clickhouse_run_select_query` with args:
```json
{
  "query": "\nSELECT \n    hugo_gene_symbol,\n    variant_type,\n    COUNT(*) as event_count,\n    COUNT(DISTINCT sample_unique_id) as sample_count\nFROM genomic_event_derived\nWHERE cancer_study_identifier = 'msk_chord_2024'\n  AND off_panel = true\nGROUP BY hugo_gene_symbol, variant_type\nORDER BY event_count DESC\nLIMIT 20\n"
}
```



Result from `clickhouse_run_select_query`:
```json
{"rows":[{"hugo_gene_symbol":"EML4","variant_type":"structural_variant","event_count":211,"sample_count":207},{"hugo_gene_symbol":"RTEL1-TNFRSF6B","variant_type":"mutation","event_count":137,"sample_count":126},{"hugo_gene_symbol":"KIF5B","variant_type":"structural_variant","event_count":91,"sample_count":83},{"hugo_gene_symbol":"CD74","variant_type":"structural_variant","event_count":75,"sample_count":68},{"hugo_gene_symbol":"PTPRK","variant_type":"structural_variant","event_count":33,"sample_count":33},{"hugo_gene_symbol":"RSPO3","variant_type":"structural_variant","event_count":32,"sample_count":32},{"hugo_gene_symbol":"EWSR1","variant_type":"structural_variant","event_count":29,"sample_count":29},{"hugo_gene_symbol":"TFG","variant_type":"structural_variant","event_count":26,"sample_count":26},{"hugo_gene_symbol":"ADGRG7","variant_type":"structural_variant","event_count":26,"sample_count":26},{"hugo_gene_symbol":"CCDC6","variant_type":"structural_variant","event_count":24,"sample_count":22},{"hugo_gene_symbol":"NRG1","variant_type":"structural_variant","event_count":23,"sample_count":23},{"hugo_gene_symbol":"TACC3","variant_type":"structural_variant","event_count":22,"sample_count":19},{"hugo_gene_symbol":"SDC4","variant_type":"structural_variant","event_count":17,"sample_count":17},{"hugo_gene_symbol":"SND1","variant_type":"structural_variant","event_count":16,"sample_count":14},{"hugo_gene_symbol":"EZR","variant_type":"structural_variant","event_count":15,"sample_count":14},{"hugo_gene_symbol":"NAB2","variant_type":"structural_variant","event_count":14,"sample_count":14},{"hugo_gene_symbol":"NCOA4","variant_type":"structural_variant","event_count":10,"sample_count":8},{"hugo_gene_symbol":"ETV4","variant_type":"structural_variant","event_count":10,"sample_count":10},{"hugo_gene_symbol":"SEC16A","variant_type":"structural_variant","event_count":9,"sample_count":8},{"hugo_gene_symbol":"PAX8","variant_type":"structural_variant","event_count":8,"sample_count":8}]}
```


## Answer

In the MSK-CHORD study, **1.02%** of genomic events occur in genes that are off-panel (not covered by the sequencing panel used).

### Breakdown by Variant Type:

| Variant Type | Total Events | Off-Panel Events | Off-Panel % |
|--------------|--------------|------------------|-------------|
| **Mutations** | 208,214 | 150 | 0.07% |
| **Copy Number Alterations (CNA)** | 60,787 | 0 | 0.0% |
| **Structural Variants** | 10,211 | 2,699 | **26.43%** |
| **Overall** | **279,212** | **2,849** | **1.02%** |

### Key Findings:

1. **Structural variants have the highest off-panel rate** at 26.43%, meaning more than 1 in 4 structural variants involve genes not covered by the MSK-IMPACT panels.

2. **Mutations are rarely off-panel** (0.07%), indicating the MSK-IMPACT panels effectively capture most point mutations and indels.

3. **No off-panel CNAs were detected**, suggesting copy number analysis is restricted to panel genes.

4. **Most common off-panel genes** are fusion partners in structural variants, including:
   - **EML4** (211 events) - commonly fused with ALK in lung cancer
   - **KIF5B** (91 events) - another ALK fusion partner
   - **CD74** (75 events) - ROS1 fusion partner
   - **RTEL1-TNFRSF6B** (137 mutation events)

This pattern makes biological sense: while the MSK-IMPACT panels are designed to capture mutations in cancer-related genes, structural variants (fusions) can involve partner genes that aren't necessarily cancer drivers themselves but are important for identifying actionable alterations.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 25.7118061799556
- **agent_type**: mcp-clickhouse

### Usage
- **input_tokens**: 49996
- **output_tokens**: 1385
- **total_tokens**: 51381
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 12:51:36*